Clinical trial
Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers
NCT01729468 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers
- Lead sponsor
- University Hospital, Tours
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 27, 2012
- Completion date
- October 25, 2016
- Enrollment
- 1,106 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
intra-uterine growth restriction, pre-eclampsia